Replies to post #10627 on Revive Therapeutics Ltd (RVVTF)

[powerbattles]

NIAID conducts and supports research — at NIH, throughout the United States, and worldwide. This is the goverment program design to speed up treatment and vaccine. We on phase 3 that is consider most promise treatment covid-19 there only a few companies that qualify on phase 3. Furthermore, other phase3 treatment fail that give us a great opportunity to be the first treatment for Covid-19. For that matter I don't see a reason why they deny us? Beside the CEO stated select location in the US indicated align with NIAID program supports research

The new study is one of four ongoing or planned trials in the National Institutes of Health’s. Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) program, a public-private partnership to speed development of the most promising treatments and vaccine candidates. It also is receiving support through Operation Warp Speed(link is external), the U.S. government’s multi-agency effort to develop, manufacture and distribute medical countermeasures to fight COVID-19.

"The trial will take place at select hospitals around the world that are part of existing clinical trial networks.

https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trial-test-antibody-treatment-hospitalized-covid-19-patients